Global Cutting Balloons Market -2024-2031

Global Cutting Balloons Market -2024-2031

Global cutting balloons market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.

A cutting balloon is a medical device used by interventional cardiologists to treat blockages in blood vessels. Typically used in the coronary arteries, the device is made up of a balloon mounted on a catheter. However, unlike traditional angioplasty balloons, it has small blades or wires on its surface. The blades or wires can cut through the plaque or tissue when the balloon is inflated at the site of the blockage, allowing for the expansion of the artery and improved blood flow.

Cutting balloons are often used in cases where conventional angioplasty alone may not effectively treat severe or resistant lesions, providing a valuable tool for restoring blood flow in patients with coronary artery disease.

Market Dynamics: Drivers and Restraints

Innovative cutting balloons used to address blockages in coronary arteries are expected to drive market growth

A new coronary-scoring balloon dilatation catheter called Naviscore was introduced by iVascular in 2023. It is a hybrid design that combines the favorable elements of cutting and scoring balloons. Unlike other contemporary scoring balloons, Naviscore has a unique construction and innovative features that overcome its existing drawbacks.

One of the unique features of the Naviscore device is a nylon compensation tube in the shaft that assists in re-wrapping after the balloons have been deflated. This feature cannot be found in any other device currently available on the market.

Compared to competitor devices, Naviscore has a similar crossing profile to a conventional balloon catheter and is capable of modifying fibrous or mildly calcified plaques before stent implantation. The device is intended to tackle complex lesions such as fibrotic plaque, calcified lesions, and in-stent restenosis.

Therefore, the Naviscore device is a significant advancement in the design of coronary scoring balloon dilatation catheters. Its unique construction and hybrid design overcome the existing drawbacks of contemporary scoring balloons. This makes it an attractive option for the percutaneous approach of restenotic coronary lesions. The device offers a range of features that further enhance its appeal.

Restraint:

Increasing competition from alternative interventional cardiology techniques and devices, the high cost of these specialized devices, and limited reimbursement policies are the factors expected to hamper the market over the forecast period.

For more details on this report – Request for Sample

Segment Analysis

The global cutting balloons market is segmented based on the product type, application, diameter range, end-user and region.

The semi-compliant cutting balloons from the product type segment accounted for approximately 34.4% of the cutting balloons market share

Semi-compliant cutting balloons are specialized medical devices used in interventional cardiology to treat blockages in coronary arteries. These balloons are unique as they combine the properties of both compliant and non-compliant balloons. They are composed of a balloon mounted on a catheter with small blades or wires on their surface. When inflated at the site of a blockage, these blades or wires can cut through the plaque or tissue, while the balloon itself conforms to the vessel's shape. Overall, semi-compliant cutting balloons provide a more effective and precise option for treating coronary artery blockages.

There are several advantages to using a semi-compliant design for medical procedures, such as precise plaque modification, reduced risk of dissection, and decreased chances of vessel injury. The market for semi-compliant cutting balloons is driven by various factors, including their effectiveness in treating complex coronary lesions, the increasing prevalence of coronary artery disease, product launches by key market players, and the constant demand for minimally invasive cardiovascular procedures.

For instance, on June 26, 2023, Boston Scientific Korea launched the Wolverine Cutting Balloon Dilatation Device, which is a catheter designed to be used in percutaneous coronary intervention (PCI). PCI is a minimally invasive treatment that employs balloon catheters or stents to widen narrowed coronary arteries and improve blood flow to the heart.

Geographical Analysis

North America accounted for approximately 41.3% of the market share in 2022

North America is expected to hold the largest market share, owing to the increasing prevalence of coronary artery disease, well-established healthcare infrastructure and access to advanced medical procedures.

For instance, according to a report by the Centers for Disease Control and Prevention in 2023, the United States experiences a high incidence of heart attacks, with one occurring roughly every 40 seconds. This has led to a significant demand for cutting balloons in the medical market. With approximately 805,000 heart attack cases annually, including both first-time incidents and those affecting individuals who have previously experienced heart attacks, there is a substantial patient population requiring effective coronary interventions.

Cutting balloons are known for their precision in plaque modification and reduced dissection risk, making them a vital tool in treating complex coronary lesions and addressing the consequences of heart attacks.

Furthermore, around 1 in 5 heart attacks go unnoticed, causing silent damage. This emphasizes the need for interventional procedures involving cutting balloons to restore blood flow and minimize cardiac complications. As a result, there is an increasing market for such specialized devices in the United States, as they play a critical role in managing the aftermath of heart attacks and preventing future cardiac issues. Hence, owing to the above factors, the North American region is expected to hold the largest market share over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic had both direct and indirect effects on the market for cutting balloons. Directly, the pandemic caused disruptions in healthcare systems and hospital resources, leading to delays in elective and non-urgent procedures, including certain interventional cardiology interventions that involve the use of cutting balloons. This resulted in a temporary decline in the demand for these devices, as healthcare resources were redirected toward COVID-19 patients.

Indirectly, the pandemic highlighted the importance of cardiovascular health, as individuals with pre-existing heart conditions were at a higher risk of severe COVID-19 outcomes. This increased awareness may have driven a resurgence in the use of cutting balloons and other cardiovascular interventional procedures in the long term, as healthcare systems adapted to the new normal and prioritized cardiac care.

Furthermore, the pandemic emphasized the significance of developing and utilizing minimally invasive treatments, which are areas in which cutting balloons excel. Therefore, while the short-term impact of COVID-19 was disruptive to the cutting balloon market, the long-term implications emphasized the importance of cardiovascular health, potentially leading to increased demand for these devices.

Market Segmentation:

By Product Type
• Non-compliant Cutting Balloons
• Semi-compliant Cutting Balloons

By Application
• Coronary Artery Disease
• Peripheral Artery Disease

By Diameter Range
• Small Diameter Cutting Balloons
• Large Diameter Cutting Balloons

By End-User
• Hospitals
• Cardiac Catheterization Laboratories
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the cutting balloons market include Boston Scientific Corporation, Ridgeback Technologies, Lepu Medical Technology (Beijing)Co. Ltd., and NIPRO CORPORATION among others.

Key Development
• On June 26, 2023, Boston Scientific Korea launched the Wolverine Cutting Balloon Dilatation Device, which is a catheter designed to be used in percutaneous coronary intervention (PCI). PCI is a minimally invasive treatment that employs balloon catheters or stents to widen narrowed coronary arteries and improve blood flow to the heart.

Why Purchase the Report?
• To visualize the global cutting balloons market segmentation based on product type, application, diameter range, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cutting balloons market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global cutting balloons market report would provide approximately 51 tables, 59 figures, and 189 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies